Abstract: A roof integrated solar power system includes a plurality of solar modules. Each solar module carries a photovoltaic or solar panel with solar cells. Edge regions of the solar module are disposed to the sides of the solar panel and are devoid of solar cells. An electrical component such as a junction box or micro-inverter, or DC optimizer is mounted on top of the solar module within at least one of the edge regions. Cabling for interconnecting the electrical component to electrical components of others of the plurality of solar modules also is located within the side regions. In one embodiment, the electrical component and cabling is disposed within a recess within a side region and covered by a flat access panel. In another embodiment, the electrical component and cabling is located atop the side region and is covered by an access panel in the form of a protective cover strip.

Abstract: An apparatus for guidance and retention of integrated circuit boards includes a first structure configured to receive a first integrated circuit board and guide the first integrated circuit board for coupling to a substrate. The apparatus further includes a second structure configured to be removably coupled to the first structure. The second structure includes a first spring member configured to apply a first compressive force to the first integrated circuit board.

Abstract: In some embodiments, the present disclosure relates to a system. The system includes a substrate and a fluid capture material formed on one or more surfaces of the substrate. The fluid capture material includes a sorbent material that binds one or more fluids, the one or more fluids comprising water, carbon dioxide, sulfur oxides, or a combination thereof. The fluid capture material also includes one or more binder materials, wherein the binder material is at least partially cross-linked.

Abstract: Described herein are personal care compositions (e.g., bar soaps) that may include from about 0.1 to about 5 wt. % of a polysaccharide; from about 0.01 to about 12 wt. % of a fatty alcohol; and from about 0.5 to about 7 wt. % of a post-biotic blend, wherein all weight percentages are based on the total weight of the personal care composition. Methods of making and using the personal care compositions are also described herein.

Abstract: Personal care compositions and methods for improving skin are disclosed. A personal care composition according to an aspect of the disclosure that may be in the form of an intimate care product and include from about 0.5 to about 7 wt. % of a post-biotic blend; optionally, from about 0.1 to about 5 wt. % of a polysaccharide; optionally, from about 0.01 to about 12 wt. % of a fatty alcohol, wherein all weight percentages are based on the total weight of the personal care composition. A method according to an aspect of the disclosure may include applying an intimate care composition to a section of skin; rinsing the section of skin; and applying a lotion composition to the section of skin.

Abstract: A system and method for capturing and automated processing aerial images of structures to assess structural damage is disclosed. The system comprises a computing system used to obtain images of selected locations associated with known structures at different points in time before and after a natural disaster. The images are used to automatically create three-dimensional models that are used to detect the specific portions of a structure that may be damaged as well as the spatial extent of that damage. In addition, the imagery can be fed into a damage classifier that automatically classifies the degree of damage and generates accurate estimates of repair costs. The system and method may be deployed to quickly assess damage of structures in a disaster area and provide reports of the damage to homeowners and/or insurers.

Abstract: A method includes obtaining a dataset that includes health data in a Fast Healthcare Interoperability Resources (FHIR) standard. The health data includes a plurality of healthcare events. The method includes generating, using the dataset, an events table that includes the plurality of healthcare events and is indexed by time and a unique identifier per patient encounter. The method also includes generating, using the dataset, a traits table that includes static data and is indexed by the unique identifier per patient encounter. The method includes training a machine learning model using the events table and the traits table and predicting, using the trained machine learning model and one or more additional healthcare events associated with a patient, a health outcome for the patient.

Abstract: A ferro-magnetic material recovery system includes a drum rotating within a magnet housing. An array of magnets mounted within the magnet housing have corresponding magnetic fields which decrease in strength in the direction of rotation of the drum to extract the material from a slurry flowing through the drum. Flow deflectors may be mounted in the drum. The array of magnets may form a magnetic core having magnetic fields that are radially aligned.

Abstract: This invention relates to novel opioid derivatives of Formula I: or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R3, R4 and Z are as defined herein in the disclosure. The invention also relates to the use of such compounds for the treatment or prevention of, for example, pain.

Abstract: A water recovery system including a first fluid stream inlet providing for the flow of a first fluid stream, such as a humidified inlet gas, into the system and a second fluid stream inlet providing for the flow of a second fluid stream, such as a gas having a temperature greater than the humidified inlet gas, into the system. At least one contactor is in fluid communication with the first fluid stream inlet and the second fluid stream inlet.

Abstract: A device comprising a modified porous membrane is provided. The modified porous membrane comprises a polymer coating grafted to a porous membrane. The device is used for analyte detection from a biological sample using an immunoassay. The device comprises a sample application zone at one end of the device for applying a biological sample comprising a target analyte; and a detection zone present at another end of the device, downstream of the sample application zone for detecting the target analyte, wherein the detection zone comprises one or more first biomolecules immobilized on a modified porous membrane having a structure of Formula (I).

Abstract: A system and method for controlling an amount of outgassing caused by implanting ions into a photoresist disposed on a workpiece. The amount of outgassing is based on the species being implanted, the type of photoresist, the energy of the implant, and the amount of dose that has already been implanted, among other effects. By controlling the effective beam current, the amount of outgassing may be maintained below a predetermined threshold. By developing and utilizing the relationship between effective beam current, dose completed and rate of outgassing, the effective beam current may be controlled more precisely to implant the workpiece in the most efficient manner while remaining below the predetermined outgassing threshold.

Abstract: A water recovery system including a first fluid stream inlet providing for the flow of a first fluid stream, such as a humidified inlet gas, into the system and a second fluid stream inlet providing for the flow of a second fluid stream, such as a gas having a temperature greater than the humidified inlet gas, into the system. At least one contactor is in fluid communication with the first fluid stream inlet and the second fluid stream inlet.

Abstract: A device for rapid detection of a tuberculosis lipoarabinomannan (TB-LAM) is provided. The device includes a pre-concentrator unit for concentrating the TB-LAM comprising: an ion-exchange medium comprising one or more ligands configured to capture the TB-LAM from the source biological sample, wherein the captured-TB-LAM is eluted from the ion-exchange medium as an eluate comprising a concentrated form of TB-LAM; a cassette; a lateral flow assay unit disposed in the cassette; and an integration unit attached to the pre-concentrator unit and the cassette. The integration unit is configured to operatively couple and de-couple the pre-concentrator unit and the cassette. The pre-concentrator unit and the lateral flow assay unit disposed in the cassette are in a fluidic communication in a coupled form. The device for rapid detection of TB-LAM further comprises a dilutor unit.

Abstract: The disclosure describes methods of treating humans with Duchenne muscular dystrophy by providing doses of an AAV9 vector that expresses a mini-dystrophin protein in transduced muscle cells.

Abstract: A rapid detection method of a target biomolecule comprising an antigenic moiety is provided. The method includes providing a source biological sample comprising the target biomolecule; contacting the source biological sample to an ion-exchange medium; eluting the captured-target biomolecule from the ion-exchange medium as an eluate, and loading the eluate to a rapid diagnostic testing device comprising an antibody. The eluate comprises a concentrated form of the biomolecule in a solution having a salt concentration greater than 150 mM. A concentration of the target biomolecule in the eluate is in a range from about 2× to 25× compared to a concentration of the biomolecule in the source biological sample. The target biomolecule binds to the antibody under the salt concentration of greater than 150 mM. A device for rapid detection of target biomolecule is also provided.

Abstract: A system and method for controlling an amount of outgassing caused by implanting ions into a photoresist disposed on a workpiece. The amount of outgassing is based on the species being implanted, the type of photoresist, the energy of the implant, and the amount of dose that has already been implanted, among other effects. By controlling the effective beam current, the amount of outgassing may be maintained below a predetermined threshold. By developing and utilizing the relationship between effective beam current, dose completed and rate of outgassing, the effective beam current may be controlled more precisely to implant the workpiece in the most efficient manner while remaining below the predetermined outgassing threshold.

Abstract: A headborne attachment platform includes multiple rigid plates and straps of connecting material connecting the rigid plates in an assembly at independently selectable and pre-set distances apart from each other. The assembly of rigid plates is shaped and connected to sit adjacent to, and surround, the bone regions of a wearer's skull, and define an overall headgear shape and contour. The straps are more flexible than the rigid plates in directions perpendicular to the thickness of the straps, and the straps are inelastic in a direction of a length thereof. A tightening mechanism is configured to adjust a circumference of a headband region, and the rigid plates have mounting features configured to mount an outer helmet shell and/or a headborne device. The rigid plates are sufficiently rigid to support and maintain their three-dimensional shape when subjected to forces exerted upon them by the outer helmet shell or headborne device.

Abstract: The invention relates to a moisture-protected electrical connection between a flat conductor and an insulated cable with a different cross-section to this and a soldering point, wherein a stripped, exposed cable end is surrounded by a solder foot or a cable end sleeve at the soldering point and is in material contact with an end of the flat conductor, and also a protective body.

Abstract: The present invention relates to compounds as defined herein, which are activators of long form cyclic nucleotide phosphodiesterase-4 (PDE4) enzymes (isoforms) and to therapies using these activators. In particular, the invention relates to these activator compounds for use in a method for the treatment or prevention of disorders requiring a reduction of second messenger responses mediated by cyclic 3?,5?-adenosine monophosphate (cAMP).